期刊文献+

基于2D分子指纹的分子相似性方法在虚拟筛选中的应用 被引量:5

Application of 2D molecular fingerprints based on molecular similarity in visual screening
下载PDF
导出
摘要 随着计算机技术迅速发展和化合物库分子数量的剧增,分子相似性在药物虚拟筛选中的应用也越来越广泛。描述符是分子相似性方法主要组成部分之一,目前已经有大量的描述符应用于分子相似性,本文总结了2D分子指纹的分类和发展,以及基于2D分子指纹的相似性方法在虚拟筛选中的应用。 Molecular similarity is widely used in visual drug screening and QSAR/QSPR. It is known that the quality of a prediction model normally depends on the molecular descriptors that quantify structural features rele- vant to the properties of interest. Many molecular descriptors have been designed to capture the characteristics of structural information. Among them, molecular fingerprints could provide the most detailed description of molecu- lar structures, as evidenced by the fact that they are routinely used and very efficient in the molecular similarity analysis. This paper reviews the recent progress in the application of 2D molecular fingerprints in visual drug screening.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2009年第2期178-184,共7页 Journal of China Pharmaceutical University
关键词 分子指纹 分子相似性 虚拟筛选 molecular fingerprint molecular similarity visual screening
  • 相关文献

参考文献24

  • 1Johnson AM, Maggiora GM. Concepts and applications of molecular similarity[ M]. New York : Wiley, 1990.
  • 2Leach AR, Gillet VJ. An Introduction to chemoinformatics [ M ]. Dordrecht : Kluwer Academic Publishers,2003.
  • 3Gasteiger J. Handbook of chemoinformatics [ M ] . Wiley-VCH : Weinheim,2003.
  • 4Willett P, Barnard JM, Downs GM. Chemical similarity searching [J]. J Chem Inf Comput Sci,1998,38(6) :983 -996.
  • 5Waiters WP, Stahl MT, Murcko MA. Virtual screening-an overview[J]. Drug Discov Today,1998,3(4) :160 -178.
  • 6Sheridan RP, Kearsley SK. Why do we need so many chemical similarity methods ? [ J ]. Drug Discov Today, 2002,7 ( 17 ) : 903 -911.
  • 7Bajorath J. Integration of virtual and high-throughput screening [ J ]. Nat Rev Drug Discov ,2002,1 ( 11 ) :882 - 894.
  • 8Monev V. Introduction to similarity searching in chemistry [ J ]. Match Commun Math Comput Chem ,2004,51:7 - 38.
  • 9Willett P. Similarity-based virtual screening using 2D fingerprints [J]. Drug Discov Today,2006,11(23-24) :1 046 -1 053.
  • 10Maldonado G, Doucet JP, Bo-Tao Fan, et al. Molecular similarity and diversity in chemoinformatics: From theory to applications [J]. Mol Divers,2006,10( 1 ) :39 -79.

同被引文献66

  • 1张丹,董一珠,吕锦涛,张晓朦,林志健,张冰.基于网络药理学与分子对接方法探讨昆明山海棠的毒性机制[J].北京中医药大学学报,2019,42(12):1006-1015. 被引量:14
  • 2李洪林,沈建华,罗小民,沈旭,朱维良,王希诚,陈凯先,蒋华良.虚拟筛选与新药发现[J].生命科学,2005,17(2):125-131. 被引量:42
  • 3李仁利.三维以上定量构效关系[J].国际药学研究杂志,2007,34(4):241-245. 被引量:5
  • 4WHO. Hepatitis B[ EB/OL]. 2013 [201307 ] http: //www. who. int/mediaeentre/factsheets/fs204/en/.
  • 5Malik AH, Lee WM. Chronic hepatitis B virus infection:treatment strategies for the next millennium[ Jl. Ann Intern Med ,2000,132 (9) :723 -731.
  • 6Zoulim F, Poynard T, Degos F, et al. A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine [ J ]. J Viral Hepat , 2006,13(4) :278 -288.
  • 7Yang HI, Lee JH, Kim YJ, et al. Antiviral efficacy of combination therapy with enteeavir and adefovir for enteeavir/lamivudine- resistant hepatitis B virus with or without adefovir resistance[ J].J Med Viro1,2012,84(3 ) :424 -430.
  • 8Litwin S, Toll E, Jilbert AR, et al. The competing roles of virus replication and hepatocyte death rates in the emergence of drug- resistant mutants : theoretical considerations [ J ]. J Clin Virol, 2005,34 ( Suppl 1 ) : $96 - $107.
  • 9Davis BJ, Erlanson DA. Learning from our mistakes: the 'unknown knowns' in fragment screening[J]. Bioorg Med Chem Lett,2013,23(10) :2 844 -2 852.
  • 10Chen L, Li YY,Zhao Q,et al. ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive parti- tioning and naive bayesian classification techniques [ J ]. Mol Pharm,2011,8(3) :889 -900.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部